Patient Characteristics
| Patient no. | Age (y) | Sex | Risk factor* | Child–Pugh score | Okuda score (I–III) | CLIP score (0–6) | PVT | Previous treatment† (interval in wk) |
|---|---|---|---|---|---|---|---|---|
| 1‡ | 70 | M | HCV | B9 | II | 2 | No | None |
| 2‡ | 71 | M | ALC | B9 | II | 3 | No | 131I (16) |
| 3 | 60 | M | None | B7 | I | 2 | No | Chemotherapy IV (22) |
| 4 | 61 | F | HCV | B9 | II | 3 | No | Resection (56) |
| 5 | 48 | M | ALC | B7 | I | 3 | No | Tamoxifen |
| 6 | 77 | M | None | B7 | II | 2 | Yes | None |
| 7 | 75 | M | ALC | B8 | II | 3 | Yes | None |
| 8 | 59 | F | HCV | B7 | II | 2 | No | None |
| 9 | 54 | M | HC, ALC | B9 | II | 4 | Yes | None |
| 10 | 68 | F | ALC | B7 | I | 4 | Yes | 131I (12) |
| 11 | 44 | M | HCV | B7 | II | 2 | No | TACE (22) |
| 12‡ | 72 | M | HCV | B7 | I | 1 | No | 188Re (18) |
↵* Risk factors: HCV = chronic hepatitis C infection; ALC = alcohol; HC = hemochromatosis.
↵† Recent previous treatment: radionuclide therapy by means of 131I-lipiodol (131I) or 188Re-HDD/lipiodol (188Re); IV = intravenous.
↵‡ Patients included in initial phase I study (11).
CLIP = Cancer of the Liver Italian Program; PVT = portal vein thrombosis.